🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a comparative interventional study to determine the best way to pre...
Status
Recruiting
Location
Alexandria University Hospitals
Start Date
2025-03-01
Trial ID
NCT07300735
Treatments Being Tested
This study is to assess the onset of action of fixed drug combination of az...
Status
Completed
Location
Inflamax Research
Start Date
2017-01-07
Trial ID
NCT03004131
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
The study is an open-label, randomized,2-period, single dose, crossover stu...
Status
Completed
Location
Eurofins Optimed
Start Date
2024-04-23
Trial ID
NCT06147622
Treatments Being Tested
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
This is a single-center, randomized, double-masked, parallel study. In this...
Status
Completed
Location
Andover Eye Associates
Start Date
2021-12-14
Trial ID
NCT05265910
Treatments Being Tested
To evaluate the bioequivalence of one extended release combination (loratad...
Status
Completed
Location
Frontage Clinical Services
Start Date
2018-04-24
Trial ID
NCT03517943
The purpose of this study is to collect information on unexpected adverse r...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00762983
Treatments Being Tested
To compare the single-dose oral bioavailability of loratadine 10 mg orally ...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00776282
Treatments Being Tested
Non-Ergot Dopamine agonists are meanwhile the drugs of first-choice in the ...
Status
Completed
Location
Dr. Erich Scholz
Start Date
2009-06
Trial ID
NCT01519856
Treatments Being Tested